Campus alert status is yellow: For the latest UMMS campus alert status, news and resources, visit umassmed.edu/coronavirus

Search Close Search

The RNA promise


The RNA Promise


Developing Breakthrough RNA Therapeutics


By interweaving nucleic acid scientists with clinicians dedicated to finding new cures, our goal is to create a new paradigm for organizing molecular research that enables the rapid application of new biological discoveries to solutions for unmet challenges in human health. Our current focus is on COVID-19Huntington’s disease,  alpha-1 antitrypsin deficiencyviral infectionspreeclampsia, cancer, and more.

RTI Spotlight

Niko Grigorieff is elected into the National Academy of Sciences!


Cryo-EM pioneer Nikolaus Grigorieff, PhD, has been elected to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

“I am grateful to all my colleagues for their support over the past 20 years,” said Dr. Grigorieff, Howard Hughes Medical Institute Investigator and professor of RNA therapeutics.

Grigorieff uses a 300,000-volt electron microscope to see molecules that operate as minute biological “machines” inside of cells. He writes his own specialized computer software to transform data from the microscope into vivid, three-dimensional images of cell components. He has a PhD from the University of Bristol in the United Kingdom, and has been investigator of the Howard Hughes Medical Institute since 2000.


Support Us


Help Us Fund Our Next Breakthrough


For decades, scientists at the University of Massachusetts Medical School have been pioneers in RNA biology and leading innovators in the development of information-based therapeutics: cutting-edge therapeutic tools that leverage our advanced understanding of the human genome in ways that are revolutionizing how we treat disease. With your support, we are poised to unleash their power, and change the world for the better.

Support Us

Page Menu